Summary

Overview
Global high pressure homogenizer market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
High pressure homogenizers are the equipment used for the homogenization of compounds that require high pressure for the processes. High pressure homogenizers are often the solution particularly useful in the pharmaceutical and biotech industries. High pressure homogenizers are especially used to prepare nanomaterial by producing high flow velocity through a small orifice, using a specially designed internal fixed geometry under ultra-high pressure that is up to 60,000 psi.
During the homogenization process, changes in physical, chemical and structural properties occur and as a result, the homogeneous suspension takes place at the nanoscale. The pressure of a conventional homogenizer is within 15,000 psi, while a high pressure homogenizer can achieve 30,000 psi and an ultra high pressure homogenizer can reach up to 60,000 psi. High pressure homogenizer applications require the most efficient fluid processing equipment, especially for particle and droplet size reduction and cell disruption.
Market Dynamics: Drivers
Increasing adoption of high-pressure homogenizers in the pharmaceutical industry
The increasing adoption of high-pressure homogenizers in the pharmaceutical industry is expected to drive the market over the forecast period. High-pressure homogenizers are very crucial in the pharmaceutical industry, especially for drug formulation. They help in achieving the desired particle size distribution and consistency in drug formulations. This is particularly important for improving drug delivery and bioavailability in the pharmaceutical industry.
For instance, on September 20, 2023, Avestin launched the EmulsiFlex-B15 high-pressure homogenizer, it offers adjustable, consistent homogenizing pressures of up to 45,000 psi, making it suitable for even the toughest of samples. The B15 also has a sample capacity of 3-15mL (batch), making it ideal for small-volume and/or high-value samples, which is why it is widely used across the pharma industries.
The pharmaceutical industries often require nanoparticles for drug delivery systems. High-pressure homogenizers can reduce particle sizes to the nanoscale, enhancing the solubility and bioavailability of drugs. For instance, on June 14, 2023, Khon Kaen University (KKU) joined hands with Lily Pharma to launch the Lily high-pressure nano homogenizer machine for advanced production technology, revolutionizing the industry and upgrading the quality of medicine and cosmetics. By using nanoemulsion technology that can use active ingredients more efficiently.
In addition, high-pressure homogenizers are also used in bioprocessing for cell disruption, which is essential for releasing the cellular contents for further processing. This is important in the production of biopharmaceuticals and vaccines. High-pressure homogenizers contribute to the quality and safety of pharmaceutical products. They also help in creating stable emulsions and reducing the risk of particle agglomeration by ensuring product consistency and safety.
Further, the increasing demand for high-pressure homogenizers in various industries, increasing awareness and increasing technological advancements in high-pressure homogenizers are the factors expected to drive the market over the forecast period.
Restraints
Factors such as complications associated with the high pressure homogenizers such as clogging, high production costs and sensitivity and heat stability are the factors expected to hamper the market over the forecast period.
Segment Analysis
The global high pressure homogenizer market is segmented based on capacity, application, end-user and region.
The cell disruption segment accounted for approximately 42.6% of the high pressure homogenizer market share
The cell disruption segment is expected to hold the largest market share over the forecast period. High-pressure homogenizers have the ability to effectively rupture cells by subjecting them to high shear forces, turbulence and pressure. This further results in a higher yield of intracellular components like enzymes and proteins from bacteria, fungi and animal cells through cell rupture. So, many market key players are focussing on the development of high pressure homogenizers for cell disruption.
For instance, on August 22, 2022, GEA introduced the XStream lab homogenizer for cell disruption and scale-up. High-pressure homogenization is used in the pharmaceutical and biotech industries primarily for cell disruption. GEA homogenizers such as the XStream Lab high pressure homogenizer can achieve cell disruption of more than 90 percent, depending on the product. Applications of homogenizers in pharmaceutical production include vaccines, intravenous emulsions, liposomes, yeast, enzymes and bacteria.
The high pressure homogenizers provide uniform and consistent cell disruption by ensuring that the released biomolecules are not denatured or degraded during the process. These homogenizers are also available in various sizes, making them suitable for both laboratory-scale and industrial-scale applications. They can be adjusted to achieve different levels of disruption, making them versatile for various cell types and applications by maintaining sterility.
Geographical Analysis
North America accounted for approximately 41.7% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing R&D activities. North America especially the United States is known for its strong presence of major players such as biopharmaceutical companies and biotechnology companies. This strong presence of major players is actively focussing on the high-pressure homogenizers and also the development of technologically advanced homogenizers.
Furthermore, increasing R&D activities in the region is also expected to drive the market due to the strong presence of research laboratories. Especially, the United States invests significantly in research and development activities across industries. High-pressure homogenizers are essential tools for R&D purposes, this further increases the demand for high pressure homogenizers in the region.
Competitive Landscape
The major global players in the high-pressure homogenizer market include Kinematica AG, LABFREEZ INSTRUMENTS GROUP CO., LTD, Microfluidics International Corporation, Duoning Biotechnology Co., Ltd., Hommak, Krones AG, GEA Group Aktiengesellschaft, Sonic Corporation, AVESTIN, Inc. and NETZSCH Vakumix GmbH among others.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global high pressure homogenizer market. During the pandemic, the pharmaceutical industry played a crucial role in the production of COVID-19 vaccines, in such situations, these high-pressure homogenizers are in demand for the production of vaccines, antiviral drugs and other pharmaceutical products. The COVID-19 pandemic also disrupted the supply chain worldwide, leading to delays in the production and delivering of high-pressure homogenizers.
Market Segmentation
By Capacity
• Less Than 1000L/H
• 1000-10000L/H
• More Than 10000L/H
By Application
• High Pressure Pasteurization
• Particle Size Reduction
• Micro/Nano Emulsions
• Dispersions
• Cell Disruption
• Others
By End-User
• Biopharmaceutical Industries
• Biotechnology Industries
• Research Laboratories
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Why Purchase the Report?
• To visualize the global high pressure homogenizer market segmentation based on capacity, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of high pressure homogenizer market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global high pressure homogenizer market report would provide approximately 61 tables, 61 figures, and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Capacity
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Adoption in Pharmaceutical Industry
4.1.2. Restraints
4.1.2.1. High Production Costs
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. Volume Analysis
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Capacity
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
7.1.2. Market Attractiveness Index, By Capacity
7.2. Less Than 1000L/H*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. 1000-10000L/H
7.4. More Than 10000L/H
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. High Pressure Pasteurization*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Particle Size Reduction
8.4. Micro/Nano Emulsions
8.5. Dispersions
8.6. Cell Disruption
8.7. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Biopharmaceutical Industries*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Biotechnology Industries
9.4. Research Laboratories
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Kinematica AG*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. LABFREEZ INSTRUMENTS GROUP CO., LTD
12.3. Microfluidics International Corporation
12.4. Duoning Biotechnology Co., Ltd.
12.5. Hommak
12.6. Krones AG
12.7. GEA Group Aktiengesellschaft
12.8. Sonic Corporation
12.9. AVESTIN, Inc.
12.10. NETZSCH Vakumix GmbH
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us